Novo Nordisk is passionate about understanding patients so it can represent them well in discussions with HCP customers. It is clear about its focus on specific diseases and understands the power of doing the basics really well. The company has an established reputation in the world of diabetes – it knows what works and executes it well.
Entry deadline | 26 August 2022 |
Extended entry deadline | 2 September 2022* *additional fee applies |
Judging Day | 6 October 2022 |
Company/Team of the Year Interviews | 21 October 2022 |
PMEA Event | 23 November 2022 |